Showing 1941-1950 of 3134 results for "".
- SCALE 2026: Practical Strategies for Treating GLP-1 RA–Related Aesthetic Changeshttps://modernaesthetics.com/news/scale-2026-practical-strategies-for-treating-glp-1related-aesthetic-changes/2487146/At the 2026 Music City SCALE meeting, Terrence Keaney, MD, discussed how dermatologists can proactively address facial aging, skin laxity, hair loss, and muscle loss associated with GLP-1 receptor agonists (RA)–mediated weight reduction. During a presentation at the 2026 Music City SCALE meeting
- SCALE 2026: Ipsen Reports Phase 2 Corabotase Data in Glabellar Lineshttps://modernaesthetics.com/news/scale-2026-ipsen-reports-phase-2-corabotase-data-in-glabellar-lines/2487141/Ipsen presented late-breaking Phase 2 data for corabotase, its investigational recombinant neuroinhibitor, in moderate-to-severe glabellar lines at the 2026 SCALE Symposium in Nashville, Tennessee. The study included 183 patients. At week 4, 66% of patients treated with corabotase 50 ng ac
- SCALE 2026: Dermatologists Navigate the Expanding Role of GLP-1 RAs in Skin Health and Aesthetic Carehttps://modernaesthetics.com/news/scale-2026-dermatologists-navigate-the-expanding-role-of-glp-1s-in-skin-health-and-aesthetic-care/2487119/Dermatologists Navigate the Expanding Role of GLP-1 RAs in Skin Health and Aesthetic Care As use of GLP-1 receptor agonists (RAs) continues to surge, dermatologists are increasingly encountering the downstream effects of these medications in both medical and cosmetic pract
- SCALE 2026: Ipsen to Present Phase II Corabotase Datahttps://modernaesthetics.com/news/scale-2026-ipsen-to-present-phase-ii-corabotase-data/2487087/Ipsen announced that Phase II data from the LANTIC trial of corabotase will be presented at the SCALE 2026 Symposium on May 16, 2026, in the first aesthetic glabellar lines indication for the investigational molecule. Corabotase is described by Ipsen as a custom-designed recombinant neuroi
- ASLMS 2026: Lumenis Reports New Laser Findings in Scalp Treatment, Rhinophyma, Photodamaged Skinhttps://modernaesthetics.com/news/aslms-2026-lumenis-reports-new-laser-findings-in-scalp-treatment-rhinophyma-photodamaged-skin/2487036/Lumenis Be Ltd. presented new clinical data on several aesthetic devices at the 45th Annual American Society for Laser Medicine and Surgery Conference, held May 7-9, 2026, in Savannah, Georgia, according to a company announcement. The presentations included data on FoLix, a 1565-nm nonabla
- Rapalogix Health Launches Re-Q Pro-Longevity Serum with Focus on Cellular Skin Aginghttps://modernaesthetics.com/news/rapalogix-health-launches-re-q-pro-longevity-serum-with-focus-on-cellular-skin-aging/2487003/Rapalogix Health has introduced its new Re-Q Pro-Longevity Face Serum during a virtual launch event on Thursday, May 7, featuring co-Founder and board-certified dermatologist Doris Day, MD, and co-Founder and CEO Rahul Mehta. The webinar focused on the science behind the product and the company’s
- Review Examines Dermatologic Effects of Rapid Weight Losshttps://modernaesthetics.com/news/review-examines-dermatologic-effects-of-rapid-weight-loss/2486984/Rapid weight loss associated with bariatric surgery, glucagon-like peptide-1 receptor agonists (GLP-1 RA), and intensive lifestyle interventions may contribute to dermatologic and structural changes that extend beyond reduced body size, according to a narrative rev
- Aesthetic Record Acquires JOYA Health to Expand Employer-Linked Skin Care Accesshttps://modernaesthetics.com/news/aesthetic-record-acquires-joya-health-to-expand-employer-linked-skin-care-access/2486904/Aesthetic Record, a widely used electronic medical record (EMR) and practice management platform in aesthetics, has announced its acquisition of JOYA Health, a company focused on employer-sponsored skin health benefits. The transaction underscores a broader trend toward specialized, consumer-driv
- Dr. Kevin Pinski Presents Injectable Pearls at Noahhttps://modernaesthetics.com/news/dr-kevin-pinski-presents-injectable-pearls-at-noah/2486902/At the 67th Noah Worcester Dermatological Society Annual Meeting, Kevin Pinski, MD, presented “Injectable Pearls,” drawing on nearly 4 decades of experience with neuromodulators, fillers, and cosmetic injectables. The presentation covered practical techniques, pati
- Cell-Assisted Lipotransfer Shows Potential in Facial and Breast Applications, Review Findshttps://modernaesthetics.com/news/cell-assisted-lipotransfer-shows-potential-in-facial-and-breast-applications-review-finds/2486650/Cell-assisted lipotransfer (CAL) continues to evolve as an adjunct to conventional fat grafting, with a recent review in Annali Italiani di Chirurgia summarizing current evidence for its use in facial and breast procedures. CAL involves enrichment of autologous fat grafts with regenerati